Anglo American PLC

Director's Dealing • Dec 19, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4670X

Anglo American PLC

19 December 2019

Anglo American plc ("the Company")

Registered office: 20 Carlton House Terrace, London SW1Y 5AN

Registered number: 3564138 (incorporated in England and Wales)

LEI: 549300S9XF92D1X8ME43

Notification of transactions by Directors and PDMRs

The Company announces the following transactions in its Ordinary Shares, pursuant to a Non-Executive Directors' 'Shares in lieu of fees' scheme. The Shares were acquired in the market using after-tax Directors' fees in respect of their services to the Company relating to the period 1 October - 31 December 2019.

In accordance with Article 19 of the EU Market Abuse Regulation, the relevant FCA notifications are set out below.

1.

Details of PDMR / person closely associated (PCA)

a)

Name

Stuart Chambers

2.

Reason for the notification

a)

Position / status

Chairman (Director/PDMR)

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Anglo American plc

b)

LEI

549300S9XF92D1X8ME43

4.

Details of the transaction(s)

a)

Description of the financial instrument

Identification Code

Anglo American plc Ordinary Shares of USD0.54945 each

GB00B1XZS820

b)

Nature of the transaction

Purchase of Shares, pursuant to a Non-Executive Directors' 'Shares in lieu of fees' scheme

c)

Currency

GBP - British Pound

d)

Price(s) and volume(s)

Price(s)	Volume(s)
GBP21.825	617

e)

Aggregated information

Aggregated volume

Price

617

GBP21.825

f)

Date of the transaction

2019-12-18

g)

Place of the transaction

London Stock Exchange - XLON

1.

Details of PDMR / PCA

a)

Name

Mphu Ramatlapeng

2.

Reason for the notification

a)

Position / status

Non-Executive Director (Director/PDMR)

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Anglo American plc

b)

LEI

549300S9XF92D1X8ME43

4.

Details of the transaction(s)

a)

Description of the financial instrument

Identification Code

Anglo American plc Ordinary Shares of USD0.54945 each

GB00B1XZS820

b)

Nature of the transaction

Purchase of Shares, pursuant to a Non-Executive Directors' 'Shares in lieu of fees' scheme

c)

Currency

GBP - British Pound

d)

Price(s) and volume(s)

Price(s)	Volume(s)
GBP21.825	165

e)

Aggregated information

Aggregated volume

Price

165

GBP21.825

f)

Date of the transaction

2019-12-18

g)

Place of the transaction

London Stock Exchange - XLON

1.

Details of PDMR / PCA

a)

Name

Jim Rutherford

2.

Reason for the notification

a)

Position / status

Non-Executive Director (Director/PDMR)

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Anglo American plc

b)

LEI

549300S9XF92D1X8ME43

4.

Details of the transaction(s)

a)

Description of the financial instrument

Identification Code

Anglo American plc Ordinary Shares of USD0.54945 each

GB00B1XZS820

b)

Nature of the transaction

Purchase of Shares, pursuant to a Non-Executive Directors' 'Shares in lieu of fees' scheme

c)

Currency

GBP - British Pound

d)

Price(s) and volume(s)

Price(s)	Volume(s)
GBP21.825	1,078

e)

Aggregated information

Aggregated volume

Price

1,078

GBP21.825

f)

Date of the transaction

2019-12-18

g)

Place of the transaction

London Stock Exchange - XLON

Clare Davage

Deputy Company Secretary

19 December 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHLIFETFILALIA